Beranda › Kanker Orofaring › Oregon › Portland
Uji klinis Kanker Orofaring di Portland, OR
4 studi untuk Kanker Orofaring mencari peserta di lokasi sekitar Portland (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Menerima pesertaFase 2
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
Menerima pesertaFase 4
- OHSU Knight Cancer Institute, Portland
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Menerima pesertaFase 3
- Providence Portland Medical Center, Portland
Uji klinis Kanker Orofaring di kota lain
- Atlanta, GA8 studi
- Edison, NJ8 studi
- Chicago, IL7 studi
- New York City, NY6 studi
- Queens, NY5 studi
- St. Louis, MO5 studi
- Tampa, FL5 studi
- Kansas City, MO5 studi
- Milwaukee, WI5 studi
- Pittsburgh, PA5 studi
- Los Angeles, CA5 studi
- Philadelphia, PA5 studi
Studi lain di Portland
- Kanker Paru Non-Sel Kecil46 studi
- Kanker (semua jenis)34 studi
- Kanker Payudara33 studi
- Kanker Prostat33 studi
- Kanker Metastatik29 studi
- Kanker Kolorektal28 studi
- Kanker Ovarium27 studi
- Kanker Paru26 studi
- Leukemia Mieloid Akut25 studi
- Kanker Endometrium24 studi
- Karsinoma Sel Skuamosa Kepala dan Leher19 studi
- Kanker Pankreas19 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.